Abstract: A system and method for authenticating an online user by using different and independent communication services to enhance security. A key server validates the factors of authentication, namely a first factor (username/password) and a second factor (key). The key server generates and sends the key to the user with a different and independent communication service, e.g., telephone, SMS or email. The user then submits the key using the online communication service. A third factor, e.g., a second password or a biometric symbol of the user, can also be used. Validation of the biometric symbol can be a prerequisite to delivery of the key to the user. A plurality of the independent services can be daisy-chained.

Abstract: The present invention relates to a physical form of the known drug substance glyburide, also known as glibenclamide, and chemically defined as 5-chloro-N-[2-[4-[[[(cyclohexylamino)-carbonyl]amino]sulfonyl]phenyl]ethyl]-2-methoxybenzamide (Merck Index, Tenth Edition, p. 642), as well as to dosage forms, e.g., tablets and capsules, incorporating said physical form of glyburide.

Abstract: A percutaneous medical insertion device for positioning a tubular member or a catheter within an interior cavity or a vein. The catheter having a flexible end portion and an opening that removeably receives a needle. The flexible end portion is essentially straight when the needle is positioned in the flexible end portion and the flexible end portion essentially curls when the needle is removed from the flexible end portion. The catheter has an opening that allows for the creation of a ninety degree angle of the catheter and simultaneously allowing a needle to be inserted through the flexible end of the catheter. After insertion into the interior cavity or the vein, the needle is removed from the catheter. The flexible end portion of the catheter curls when the needle is removed from the catheter to protect the interior of the interior cavity or the vein as the catheter is advanced.

Abstract: A percutaneous dilational medical insertion device and method comprising a needle removeably disposed in a catheter and a tubular member. The catheter has an inflatable balloon member disposed between a first catheter end and a second catheter end. The second catheter end having a flexible end portion. The needle has a tip that extends beyond the second catheter end that is percutaneously inserted into an interior cavity. After insertion into the interior cavity, the needle is removed from the catheter. When the needle is removed, the flexible end portion of the catheter curls to protect the interior cavity as the catheter is advanced. The catheter is advanced until the inflatable balloon member is received in a wall of the interior cavity. The inflatable balloon member is dilated to form a passageway. The tubular member disposed about the catheter proximate the first catheter end is then advanced into the passageway.

Abstract: The present invention relates to a physical form of the known drug substance glyburide, also known as glibenclarnide, and chemically defined as 5-chloro-N-[2-[4-[[[(cyclohexylamino)-carbonyl]amino]sulfonyl]phenyl]ethyl]-2-methoxybenzamide (Merck Index, Tenth Edition, p. 642), as well as to dosage forms, e.g., tablets and capsules, incorporating said physical form of glyburide.

Abstract: The invention is a temporary support for holding a structural member such as a fence post in an upright vertical position during vertical leveling and setting. The support comprises a removable frame that fits around a fence post. The frame has a post-retaining portion and a plurality of leg-receiving portions. The legs are slid in the leg-receiving portions and are capable of sliding in and out of the frame in order to adjustably support the fence post.

Abstract: Preferred embodiments of the present invention provide a sign system for creating extremely lightweight, reconfigurable, and changeable signs suitable for outdoor use adjacent to roadways. The system provides adjustable message screen size, electronically changeable messages and alphanumeric adjustable character size of at least 6 inches in height. The system comprises a sign controller and a plurality of interchangeable modules each sealed to be weather resistant. Each module having a display side with a rectangular screen portion, the screen portion having transparent portions with pixel elements positioned behind said transparent portions and within said module. Each module has the pixels arranged in a first matrix pattern and sufficient in number to provide alphanumeric characters and portions of characters of adjustable size of at least 6 inches. Each module having a bit map memory and being individually addressable with respect to other modules.

Abstract: The invention is a temporary support for holding a structural member such as a fence post in an upright vertical position during vertical leveling and setting. The support comprises a removable frame that fits around a fence post. The frame has a post-retaining portion and a plurality of leg-receiving portions. The legs are slid in the leg-receiving portions and are capable of sliding in and out of the frame in order to adjustably support the fence post.

Abstract: In a preferred embodiment of the invention, an outdoor sign has a plurality of display modules, each hermetically sealed, for forming a hermetically sealed large sign screen. Each module is preferably formed of a lightweight plastic enclosure with an open interior containing circuitry and light emitting diodes. Means for minimizing deflection of the front panel are incorporated into the enclosure. One such means includes a single restrictive vent for pressure equalization to minimize deflection of the face portion. The means also includes an internal diaphragm to maintain the integrity of the hermetic seal. A feature and advantage of the invention is that moisture and other containments are effectively precluded from entry into the chamber containing the circuitry and LED's of the display sign.

Abstract: The present invention relates to a physical form of the known drug substance glyburide, also known as glibenclamide, and chemically defined as 5-chloro-N-[2-[4-[[[(cyclohexylamino)-carbonyl]amino]sulfonyl]phenyl]ethyl]-2-methoxybenzamide (Merck Index, Tenth Edition, p. 642), as well as to dosage forms, e.g., tablets and capsules, incorporating said physical form of glyburide.

Abstract: The present invention relates to a solid oral dosage form comprising a combination of metformin and glibenclamide in which the size of glibenclamide is such that the glibenclamide bioavailability is comparable to the glibenclamide bioavailability obtained with a separate administration of metformin and glibenclamide.

Abstract: The present invention is a modular electronic sign having a plurality of display units assembled on a mounting track and connected to a sign controller. Each display unit has a circuit board having a plurality of light emitting diodes arranged in a pattern thereon. A microprocessor in each display unit is in communication with the sign controller and adjacent display units. Each display unit is hermetically sealed to avoid a separate enclosure for the modular sign. A plurality of clips are used to electrically connect the display units to power and communications conductors. A plurality of compression clips mechanically connect the display units to the mounting track. Each display unit is mountable to the mounting track either horizontally or vertically.

Abstract: Preferred embodiments of the present invention provide a sign system for creating extremely lightweight, reconfigurable, and changeable signs suitable for outdoor use adjacent to roadways. The system provides adjustable message screen size, electronically changeable messages and alphanumeric adjustable character size of at least 6 inches in height. The system comprises a sign controller and a plurality of interchangeable modules each sealed to be weather resistant. Each module having a display side with a rectangular screen portion, the screen portion having transparent portions with pixel elements positioned behind the transparent portions and within the module. Each module has the pixels arranged in a first matrix pattern and sufficient in number to provide alphanumeric characters and portions of characters of adjustable size of at least 6 inches. Each module having a bit map memory and being individually addressable with respect to other modules.

Abstract: The present invention is directed to a method for producing a microcapsule flavor delivery system. In the method, a mixture of a flavoring material selected from the group consisting of an oil soluble flavor dissolved in an oil and an o/w emulsion flavor and a protein solution is provided. The mixture is subjected to low shear mixing to provide an o/w water pre-emulsion. The pre-emulsion is subjected to high shear mixing or sonication to provide an o/w emulsion having a coating of protein around the internal oil droplets. The o/w emulsion is mixed with a liquified hard fat which is solid at room temperature. The mixture of hard fat and o/w emulsion is atomized onto a planar surface or into a fluid to provide microcapsules which are an o/w/o multiple emulsion having a flavoring material in the internal oil phase or o/w emulsion.

Abstract: An excavation support structure has a vertical face and includes an array of two or more soil-cement columns positioned internal to the vertical face. The columns are positioned within the array so that each of the columns is not connected by soil-cement to any other column. Soil surrounds the soil-cement columns except where the soil-cement columns meet the vertical surface. The soil-cement columns are distributed within the support structure so as to form a composite structure with the soil.

Abstract: The present invention relates to a bedding system for use in the interior of an infants crib. This invention enables the bedding to be changed quickly and easily. In its broadest context, the system employs a bumper pad which is adapted to be secured within the crib structure and a sheet which is adapted to be secured to the bumper pad. Thus, in use, the bumper pad can remain fixed to the crib structure and the sheet removed and replaced when new bedding is desired.

Abstract: A biocidal or agrochemical composition comprising particles or droplets of a substantially water-insoluble or sparingly-soluble biocidally-or agrochemically-active substance cosuspended, by an aqueous structured surfactant, with an aliphatic hydrocarbon or glyceride oil, wherein the weight ratio of said surfactant to said active substance is less than 20:1

Abstract: A medical device, for example, an IV cannula or a syringe which has a hollow needle 4 with a sharp distal end 6 for piercing the skin of a patient includes means for protecting the sharp end 6 of the needle 4 after use to minimise the possibility of accidental needle stick. The means includes a rod 12 mounted for movement through the needle 4 between a needle end protection position and a retracted position within the hollow needle 4; and means for maintaining the rod towards the needle end protection position.

Abstract: This invention relates to polymer particles that are acid-free in the swellable polymer core and to hollow polymer particles derived therefrom, and to a process for the production of these particles. The acid-free core advantageously decreases the polymer particle's affinity to water. Applicants have discovered that non-carboxylated latexes having a variety of Tg's will swell at temperatures higher than the Tg of the polymer. These latex particles are useful as opacifying plastic pigments for various coatings and particularly as gloss-enhancing plastic pigments for paper and paperboard coatings. Preparation of the hollow polymer particle comprises the use of (meth)acrylate ester monomers, vinyl esters of carboxylic acids or a mixture thereof which are hydrolyzable and swellable at higher temperatures in alkaline environments. The particles may be encapsulated with a hard shell.

Abstract: The present invention relates to a solid oral dosage form comprising a combination of metformin and glibenclamide in which the size of glibenclamide is such that the glibenclamide bioavailability is comparable to the glibenclamide bioavailability obtained with a separate administration of metformin and glibenclamide.